• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR ABSOLUTE PRO LL SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR ABSOLUTE PRO LL SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Catalog Number 1012014-150
Device Problems Mechanical Jam (2983); Activation Failure (3270)
Patient Problem Unspecified Tissue Injury (4559)
Event Date 11/26/2021
Event Type  Injury  
Manufacturer Narrative
The device is expected to be returned for investigation.It has not yet been received.A follow-up report will be submitted with all additional relevant information.
 
Event Description
It was reported that the procedure was to treat the moderately calcified left common femoral artery.A contralateral approach was taken with a non-abbott 7fr 45 cm sheath and the lesion was pre-dilated with a 5x100 mm armada percutaneous transluminal angioplasty (pta) catheter.The 5x150 mm absolute pro self expanding stent system (sess) was advanced and deployment was initiated.After about 4 cm of release it was not possible to release any more of the stent as the deployment system was stuck.Several maneuvers were attempted, including disconnection of the catheter release system, but without success.The physician opted for advancing the long introducer to the closest one to the stent, and the stent was withdrawn partially deployed.When the sess was removed it caused friction in the intima and the patient's final state was reported as "injury".A new 5x120 mm absolute pro stent was implanted to complete the procedure.Reversal of heparin was performed at the end of the procedure to reduce the possibility of hematoma at the puncture site.There was a delay in the procedure but no harm reported.Final patient outcome is good per control arteriography.No additional information was provided.
 
Manufacturer Narrative
A visual and functional analysis was performed on the returned device.The reported deployment difficulties and mechanical jam of the thumbwheel could not functionally be confirmed due to the condition of the returned unit.However, the condition of the returned unit is consistent with the reported difficulties encountered.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history revealed no indication of a lot specific product quality issue.The reported patient effect of injury to artery (rupture, perforation, dissection) is listed in the absolute pro ll instruction for use as a known possible complication that may occur with use of the device.The investigation was unable to determine a definitive cause for the reported deployment difficulties resulting in tissue injury, unexpected medical intervention, and treatment with medications.It is possible that the shaft was bent or entrapped within the anatomy (possibly at the aortic bifurcation, which was described as ¿quite accentuated¿) preventing movement of the shaft lumens causing the thumbwheel to lock up preventing further deployment.Continued force applied in the attempt to rotate the thumbwheel likely placed excessive tension on the ribbon causing the outer member to separate preventing any further transmission between the thumbwheel and distal sheath.However, this could not be confirmed.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
 
Event Description
Subsequent to the original report, on may 11th, 2022, abbott determined that a field safety notice was required for the absolute pro ll peripheral self-expanding stent system (psess).Abbott has confirmed reports of mechanical locking, stent deployment and partial stent deployment failures, resulting from unintended excessive force used to deploy the stent.To reduce occurrences of deployment failures and associated outcomes, abbott is notifying all users of the potential causes and risks.
 
Manufacturer Narrative
Although the difficulties encountered appear to be related to procedural circumstances, on may 11th, 2022, abbott determined that a field safety notice (fsn) was required for the absolute pro ll peripheral self-expanding stent system (psess).Abbott has confirmed reports of mechanical locking, stent deployment and partial stent deployment failures, resulting from unintended excessive force used to deploy the stent.To reduce occurrences of deployment failures and associated outcomes, abbott is notifying all users of the potential causes and risks.H6: investigation conclusions code 4315 removed; 4307 added.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABSOLUTE PRO LL SELF-EXPANDING STENT SYSTEM
Type of Device
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key13020580
MDR Text Key285696645
Report Number2024168-2021-11703
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
P110028
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Remedial Action Notification
Type of Report Initial,Followup,Followup
Report Date 06/01/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/16/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/31/2022
Device Catalogue Number1012014-150
Device Lot Number0012361
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/10/2022
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/11/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/23/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
AQUALINER 0.035 INCH 260 CM GUIDE WIRE; DESTINATION 7FR 45CM SHEATH
Patient Outcome(s) Disability; Required Intervention;
-
-